Novel ICL: Low adverse events in highly myopic special-needs children

The rate of adverse events was low in this higher risk, difficult-to-manage population of special-needs children, noted Margaret Reynolds, MD.

TearLab names Adam Szaronos president and CEO, and Jim Mazzo executive chairman of the Board

TearLab Corp. announced that Adam Szaronos has been appointed president and CEO by the company's Board of Directors, effective immediately.

Fraunhofer Institute creates 3D-printed prosthetic eye

Using its proprietary software, the company has been able to create models in a fraction of the time typically needed for fitting one.